ES353521A1 - Quinoline Derivatives - Google Patents
Quinoline DerivativesInfo
- Publication number
- ES353521A1 ES353521A1 ES353521A ES353521A ES353521A1 ES 353521 A1 ES353521 A1 ES 353521A1 ES 353521 A ES353521 A ES 353521A ES 353521 A ES353521 A ES 353521A ES 353521 A1 ES353521 A1 ES 353521A1
- Authority
- ES
- Spain
- Prior art keywords
- carbon atoms
- alkenyl group
- contain
- penicillin
- chain alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Pharmaceutical compositions having anticoccidiosis and anti-viral activities and containing quinoline derivatives of the general formula: wherein R represents a straight chain alkyl or alkenyl group having 7 to 11 carbon atoms, R 1 represents a straight or branched chain alkyl or alkenyl group having 1 to 4 carbon atoms, R 2 represents a methyl, ethyl, n-propyl, isopropyl or allyl group and R 3 represents hydrogen, an alkyl or alkenyl group having 1 to 6 carbon atoms, or a carboxylic acyl group with a saturated or unsaturated hydrocarbon moiety, and, when R 3 is hydrogen, salts thereof, are administered orally or parenterally in association with a physiologically innocuous carrier and if desired the compositions may contain one or more additional prophylactic or therapeutic agents, e.g. antibacterial agents such as furazolidone, or coccidiostats, such as 2-chloro-4-nitrobenzamide, pyridine-3-sulphonamide, nitrofurazone or sulphaquinoxaline. They may also contain other substances known to be useful in promoting the growth of poultry or their egg production such as 4-hydroxy-3-nitro-phenylarsonic acid and antibiotics such as penicillin and penicillin derivatives.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB20731/67A GB1188365A (en) | 1967-05-04 | 1967-05-04 | Quinoline Derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ES353521A1 true ES353521A1 (en) | 1970-01-16 |
Family
ID=10150709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES353521A Expired ES353521A1 (en) | 1967-05-04 | 1968-05-04 | Quinoline Derivatives |
Country Status (5)
Country | Link |
---|---|
CH (1) | CH485725A (en) |
DE (1) | DE1770326A1 (en) |
ES (1) | ES353521A1 (en) |
FR (2) | FR1570077A (en) |
GB (1) | GB1188365A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE68917024D1 (en) * | 1988-05-24 | 1994-09-01 | Kirin Brewery | 4 (1H) quinolone derivatives. |
-
1967
- 1967-05-04 GB GB20731/67A patent/GB1188365A/en not_active Expired
-
1968
- 1968-05-03 DE DE19681770326 patent/DE1770326A1/en active Pending
- 1968-05-03 CH CH656668A patent/CH485725A/en not_active IP Right Cessation
- 1968-05-03 FR FR1570077D patent/FR1570077A/fr not_active Expired
- 1968-05-03 FR FR150511A patent/FR7711M/fr not_active Expired
- 1968-05-04 ES ES353521A patent/ES353521A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR7711M (en) | 1970-03-02 |
GB1188365A (en) | 1970-04-15 |
FR1570077A (en) | 1969-06-06 |
DE1770326A1 (en) | 1971-10-21 |
CH485725A (en) | 1970-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1334138A (en) | Immunological adjuvatns | |
ES353413A1 (en) | Quinoline Derivatives | |
ES353521A1 (en) | Quinoline Derivatives | |
GB1153366A (en) | Substituted Benzoic Acid Lactones having Estrogenic Properties | |
GB1322112A (en) | 3,4,5-trimethoxybenzoic acid derivatives and their uses | |
GB1314952A (en) | 3,4,5-trialkoxy-benzoic acid derivatives and their uses | |
GB1352245A (en) | Azabicyclo-3.3.1-nonan-3-ol ester derivatives | |
ES427115A1 (en) | Novel benzoylphenylacetic acid derivatives | |
GB1347598A (en) | Lincomycin derivatives and the manufacture thereof | |
GB1373337A (en) | 3-alkyl-4-sulphamoylaniline derivatives | |
GB1203538A (en) | Cubane derivatives | |
ES351083A1 (en) | Dialkoxy - hydroxy - quinoline carboxylate esters having coccidiostatic and antiviral activity | |
GB1416705A (en) | Keto-esters | |
GB1332697A (en) | Benzodiazepine derivatives | |
SE300011B (en) | ||
GB1319402A (en) | 3-acyloxypropyl-2,-trimethylammoniumethyl phosphates | |
ES366690A1 (en) | 15(r)-pge1 and related compounds | |
GB1313838A (en) | 3,4,5-trialkoxybenzoic acid derivatives and their uses | |
GB1134475A (en) | Guanidine derivatives | |
GB1158954A (en) | N-(4-Carboxy-Phenyl)-Anthranilic Acid, derivatives thereof and a process for their preparation | |
GB905197A (en) | Anti-viral compositions comprising 1-phenyl-2-amino-propane-1,3-diol derivatives | |
GB1380754A (en) | Pharmaceutical compositions comprising semi-esters of dicarboxylic acids | |
ES369646A1 (en) | A procedure for the preparation of the derivatives of 5-thzolol carboxylic acid. (Machine-translation by Google Translate, not legally binding) | |
GB1173577A (en) | Improvements in or relating to New Indole Derivatives, Process for Preparing same and Therapeutic Compositions Containing them | |
GB1173636A (en) | Alkyl Phenylpiperazinylalkylcarbamates |